Hoese & Co LLP
- SEC CIK
- 0001840268
- Latest filing
- Jul 14, 2026
NVS holding history
Novartis AG in every 13F filed by Hoese & Co LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −825−100.0% | Sold out | Holders |
| Q2 2025 | 825 | $99.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 825 | $92.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 825 | $80.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 825 | $94.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 825 | $85.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 825 | $83.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 825 | $80.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 825 | $84.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 825 | $83.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 825 | $69.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 825 | $74.0K | 0.1% | −50−5.7% | Reduced | Holders |
| Q3 2022 | 875 | $67.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 875 | $74.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 875 | $77.0K | 0.1% | −400−31.4% | Reduced | Holders |
| Q4 2021 | 1,275 | $112.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 1,275 | $104.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,275 | $116.0K | 0.1% | +825+183.3% | Added | Holders |
| Q1 2021 | 450 | $38.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.